Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Moderna Therapeutics
Moderna Therapeutics
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
CNBC
Moderna Therapeutics
vaccines
Flu
flu vaccines
clinical trials
Flag link:
Moderna aims for the stars again with ambitious drug development plan
Moderna aims for the stars again with ambitious drug development plan
BioPharma Dive
Moderna Therapeutics
drug development
MRNA
Flag link:
Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?
Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?
Forbes
FDA
COVID-19
vaccines
boosters
Pfizer
Moderna Therapeutics
BioNTech
Flag link:
Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines
Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines
Fierce Pharma
Pfizer
BioNTech
Moderna Therapeutics
FDA
COVID-19
vaccines
Flag link:
Moderna, Immatics agree to a cancer-focused collab that could top $1.7B
Moderna, Immatics agree to a cancer-focused collab that could top $1.7B
Medical Marketing and Media
Moderna Therapeutics
Immatics
cancer
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
Moderna says updated COVID vaccine is effective against newer variant
Moderna says updated COVID vaccine is effective against newer variant
Yahoo/Reuters
Moderna Therapeutics
COVID-19
vaccines
Flag link:
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Fierce Pharma
Pfizer
BioNTech
Moderna Therapeutics
vaccines
MRNA
COVID-19
patents
Flag link:
Moderna reups as U.S. Open sponsor, debuts Arthur Ashe ‘changemakers’ ad
Moderna reups as U.S. Open sponsor, debuts Arthur Ashe ‘changemakers’ ad
Medical Marketing and Media
Moderna Therapeutics
vaccines
pharma marketing
Flag link:
GSK, Moderna fight over ‘COVID MVAX’ trademark. What does it mean for pharma?
GSK, Moderna fight over ‘COVID MVAX’ trademark. What does it mean for pharma?
Medical Marketing and Media
GSK
Moderna Therapeutics
trademark
vaccines
COVID-19
Flag link:
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
BioSpace
Moderna Therapeutics
CARsgen
MRNA
cancer
cancer vaccine
vaccines
solid tumors
CAR-T
Flag link:
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Fierce Biotech
Moderna Therapeutics
Claudin18.2
MRNA
vaccines
CAR-T
cancer vaccine
solid tumors
Flag link:
Moderna builds case for updated COVID shot ahead of latest booster push
Moderna builds case for updated COVID shot ahead of latest booster push
BioPharma Dive
Moderna Therapeutics
COVID-19
vaccines
boosters
Flag link:
Moderna's updated COVID vaccine effective against 'Eris' variant in humans
Moderna's updated COVID vaccine effective against 'Eris' variant in humans
Yahoo/Reuters
Moderna Therapeutics
COVID-19
vaccines
Flag link:
GSK stays a step ahead in RSV vaccine battle as Arexvy becomes available at US pharmacies
GSK stays a step ahead in RSV vaccine battle as Arexvy becomes available at US pharmacies
Fierce Pharma
GSK
RSV
vaccines
Arexvy
Pfizer
Moderna Therapeutics
Flag link:
Moderna, Regeneron post solid earnings, eye a strong finish to 2023
Moderna, Regeneron post solid earnings, eye a strong finish to 2023
Medical Marketing and Media
earnings
Moderna Therapeutics
Regeneron
Flag link:
Moderna plots lung cancer trial for Merck-partnered vax, piggybacking on Keytruda's recent win
Moderna plots lung cancer trial for Merck-partnered vax, piggybacking on Keytruda's recent win
Fierce Biotech
Moderna Therapeutics
lung cancer
Merck
vaccines
Keytruda
Flag link:
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
CNBC
Pfizer
Moderna Therapeutics
Novavax
vaccines
COVID-19
Flag link:
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Yahoo/Reuters
Moderna Therapeutics
Merck
MRNA
vaccines
skin cancer
Keytruda
clinical trials
Flag link:
Pfizer and Moderna’s parent are investing $100 million in a new partnership to find the next big drug
Pfizer and Moderna’s parent are investing $100 million in a new partnership to find the next big drug
Yahoo/Fortune
Pfizer
Flagship Pioneering
Moderna Therapeutics
R&D
drug development
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »